» Articles » PMID: 21521319

What Medical Options Should Be Considered for the Treatment of Primary Hyperparathyroidism?

Overview
Specialty Endocrinology
Date 2011 Apr 28
PMID 21521319
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Primary hyperparathyroidism (PHPT) is a common, often asymptomatic, endocrine disorder characterized by hypercalcaemia in the face of a nonsuppressed parathyroid hormone (PTH) level. For those with symptomatic disease or who meet surgical criteria, parathyroidectomy is the treatment of choice. However, those patients who do not meet surgical criteria or who cannot undergo or refuse surgery must be managed medically. Medical management of PHPT involves continual assessment to determine who will benefit from surgical intervention, replacement of vitamin D, treatment of parathyroid bone disease and management of hypercalcaemia and renal stone disease.

Citing Articles

Parathyroidectomy: is vitamin D a player for a good outcome?.

Carsote M, Paduraru D, Nica A, Valea A J Med Life. 2016; 9(4):348-352.

PMID: 27928436 PMC: 5141392.


Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism.

Tournis S, Fakidari E, Dontas I, Liakou C, Antoniou J, Galanos A J Bone Miner Metab. 2013; 32(2):151-8.

PMID: 23700284 DOI: 10.1007/s00774-013-0473-6.